1.The Role of LHPP in Breast Cancer Cell Function and Immune Regulation
Min XIANG ; Yanfeng GE ; Yifan JIANG ; Yichen ZOU ; Longfeng ZHANG ; Xiufen ZHUANG ; Yang SHU
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2026;55(1):97-103
Objective To investigate the expression level of LHPP in human breast cancer and its impact on proliferation and migration and to conduct a preliminary exploration of its immunoregulatory function. Methods The expression level of the LHPP protein was examined in breast cancer patients.To manipulate LHPP expression,breast cancer cells were transfected with overexpression plasmids (T47D) or specific shRNAs(MCF7).LHPP protein levels,along with cell proliferation,migration capacity,and Akt pathway activity,were quantified via Western blotting,CCK-8,Transwell,and related assays,respectively.A preliminary investigation was conducted to examine the role of LHPP in immune regulation. Results The expression was significantly lower in cancer tissues than in adjacent non-tumor tissues from breast cancer patients(P<0.05).LHPP expression varied across cancer cell lines,with T47D showing lower levels and MCF7 exhibiting relatively higher levels(all P<0.05).In T47D cells,LHPP overexpression successfully led to increased levels of LHPP.As a result,cell proliferation,migration,and the p-Akt/Akt ratio were significantly decreased(all P<0.05).In MCF7 cells,shLHPP transfection knocked down LHPP expression,leading to significant changes in the above-mentioned phenotypic and pathway markers(all P<0.05). Conclusion LHPP,which is expressed at low levels in breast cancer,functions as a tumor suppressor by inhibiting cancer cell proliferation and migration.This effect may be mediated through the Akt signaling pathway.
2.Application effect of preoperative muscle strength training combined with postoperative BIODEX balance training in treatment of patients with total hip arthroplasty
Zhanlei ZHANG ; Guo CHEN ; Fujuan YONG ; Shangshang ZHANG ; Mengna BI ; Yichen WANG ; Zou MA
Journal of Clinical Medicine in Practice 2024;28(2):84-87
Objective To observe the effect of preoperative muscle strength training combined with postoperative BIODEX balance function training in improving the motor function of patients with total hip arthroplasty (THA). Methods A total of 110 patients with THA from January 2021 to December 2022 were selected as research objects, and were divided into observation group and control group by the simple randomization method, with 55 cases in each group. The control group received conventional postoperative rehabilitation training, while the observation group was treated with muscle strength training and BIODEX balance function training. Imaging indicators (acetabular abduction angle, anterior inclination angle, proportion of acetabular cup in safe zone, and centering rate of femoral prosthesis) at 5 days after surgery were compared between two groups; the joint motor function (Harris score for hip joint), balance ability [Berg Balance Scale (BBS)] and daily activity ability [Activities of Daily Life Scale (ADL)] before treatment and one month after treatment were compared between the two groups. Results There were no significant differences in acetabular abduction angle, anterior inclination angle, proportion of acetabular cup in safe zone and centering rate of femoral prosthesis between the two groups at 5 days after surgery (
3.Two decomposition algorithms of dual-energy cone beam CT and their dependence on the phantom sizes
Chenguang LI ; Tianye NIU ; Li ZHOU ; Jun DENG ; Chengyuan ZOU ; Sha LI ; Hongjia LIU ; Zhengkun DONG ; Ling HUA ; Yichen PU ; Liangzi QU ; Qiao LI ; Yibao ZHANG
Chinese Journal of Radiological Medicine and Protection 2022;42(4):269-276
Objective:To analyze the effects of two decomposition algorithms of dual-energy cone beam CT (DECBCT) (direct decomposition and iterative decomposition) on the image quality and material decomposition accuracy of different sizes of phantoms.Methods:Different sizes of imaging parts of patients were simulated using the combination of CatPhan604 phantoms and customized annuluses. CBCT with high energy of 140 kVp and low energy of 100 kVp were acquired using the Varian Edge CBCT system. Then the material decomposition of DECBCT images was performed using the two algorithms. The electron density (ED) and contrast-to-noise ratio (CNR) of each material in the CTP682 module were calculated. They were used to assess the decomposition accuracy and image quality of the two algorithms.Results:Based on the values in the Catphan604 manual, both algorithms have high ED accuracy. Only the ED accuracy of four materials of the smallest sized phantom showed statistical difference ( z = -4.21, 4.30, 2.87, 5.45, P < 0.05), but the average relative error was less than 1%. The CNR of the iterative decomposition algorithm was significantly higher than that of the direct decomposition, increasing by 51.8%-703.47%. The increase in the phantom size significantly reduced the accuracy of ED, and the increased amplitude of the relative error was up to a maximum of 2.52%. The large phantom size also reduced the image quality of iterative decomposition, and the decreased amplitude of CNR was up to a maximum of 39.71. Conclusions:Compared with the direct decomposition, the iterative decomposition algorithm can significantly reduce the image noise and improve the contrast without losing the accuracy of electron density in the DECBCT construction of different sizes of phantoms.
4.Study on Preparation and Pharmacokinetics of Puerarin Microemulsion Based on Phase Ⅰ Metabolic Regulation
Liping DAI ; Wei LI ; Hongyi ZHUO ; Guirong LIU ; Yan HE ; Yichen HU ; Yu SONG ; Liang ZOU
China Pharmacy 2019;30(11):1459-1464
OBJECTIVE: To prepare puerarin microemulsion with phase Ⅰ metabolic regulation (R-PR-ME) and to study pharmacokinetic characteristics of rats in vivo. METHODS: R-PR-ME and Puerarin microemulsion without metabolic regulation (NR-PR-ME) were prepared by Shah method. Pseudo-ternary phase diagram was used to optimize microemulsion formula using drug loading amount as index. The particle size and PDI of microemulsion were characterized by using a laser particle size analyzer. Rats were used as animal models, and HPLC method was used to determine the blood concentration of puerarin before and 5, 10, 15, 20, 30, 45, 60, 90, 120, 180, 240, 360, 480, 600 min after intragastric administration of R-PR-ME, NR-PR-ME and puerarin suspension (PR-SP) at puerarin dosage of 120 mg/kg. The pharmacokinetic parameters were calculated by using DAS 2.0 software. SPSS 19.0 software was used for statistical analysis. The relative bioavailability of R-PR-ME was calculated with NR-PR-ME as reference preparation. RESULTS: The formula of R-PR-ME included that oleoyl polyoxyl-6 glyserides (oil phase)-polysorbate 20 (emulsifier)-glycerides (co-emulsifier) mass ratio of 2 ∶ 4 ∶ 4; drug-loading amount of 67.50 mg/g, particle size was (22.59±0.53) nm (n=3) and PDI was 0.182±0.017 (n=3). The formula of NR-PR-ME included that soybean oil (oil phase)-polysorbate 80 (emulsifier)- glycerol (co-emulsifier) mass ratio of 1 ∶ 4.5 ∶ 4.5, drug-loading amount of 61.32 mg/g, particle size of (15.45±1.06) nm(n=3) and PDI of 0.156±0.012 (n=3). Pharmacokinetic parameters of R-PR-ME, NR-PR-ME and PR-SP included that AUC0-600 min were (134.187±37.152), (65.145±18.762) and (49.623±12.143) μg·min/mL; cmax were (1.316±0.306), (1.082±0.294) and (0.425±0.106) μg/mL; MRT were (155.068±33.204), (100.264±27.683), (60.524±14.086) min; t1/2β were (365.880±101.250), (283.280±80.940), (80.063±21.189) min (n=6), respectively. Compared with PR-SP, AUC0-600 min, cmax, MRT and t1/2β of R-PR-ME and NR-PR-ME were increased significantly (P<0.05 or P<0.01). Compared with NR-PR-ME, AUC0-600 min, MRT and t1/2β of R-PR-ME were more higher (P<0.05). The relative bioavailability of of R-PR-ME was 205.98%. CONCLUSIONS: R-PR-ME is prepared successfully with high drug-loading amount, and can significantly increase the bioavailability of puerarin in rats, compared with PR-SP and NR-PR-ME.
5.Effects of Rutin Combined with Quercetin with Different Compatibility Ratios on the Pharmacokinetics of Rutin in Rats in vivo
Yu SONG ; Yichen HU ; Wei LI ; Gang ZHAO ; Liang ZOU ; Zhanguo WANG
China Pharmacy 2017;28(7):902-905
OBJECTIVE:To explore the effects of the different compatibility ratios of rutin with quercetin on the pharmacoki-netics of rutin in rats in vivo. METHODS:30 rats were randomly divided into rutin group(rutin-quercetin molar ratio of 4:0,the same below),quercetin group(rutin-quercetin ratio of 0:4),BL1 group(rutin-quercetin ratio of 3:1),BL2 group(rutin-quercetin ratio of 2:2)and BL3 group(rutin-quercetin ratio of 1:3),6 rats in each group,all group was administrated 10 mg/kg(calculat-ed by quercetin core of rutin and quercetin) intragastrically. The blood sample 0.3 mL was respectively taken from tail vein after 0.25,0.5,0.75,1,1.5,2,3,4,6,8,10,12,16,20,24 h of administration,the plasma concentration of quercetin(rutin me-tabolite) was determined by HPLC. DAS 2.0 software was used to calculate the pharmacokinetic parameters. RESULTS:The AUC0-24 h in rutin group,quercetin group,BL1 group,BL2 group and BL3 group were (4.908 ± 0.877),(8.382 ± 3.671), (8.473 ± 0.709),(4.366 ± 2.297),(8.914 ± 2.642)μg·h/L;MRT0-24 h were (9.675 ± 1.359),(3.142 ± 0.489),(3.517 ± 1.128), (3.376 ± 1.046),(4.494 ± 1.653) h;tmax were (5.726 ± 5.645),(1.375 ± 0.703),(1.125 ± 1.438),(1.417 ± 2.300),(1.292 ± 0.954) h;and cmax were (0.609 ± 0.202),(2.341 ± 0.539),(2.425 ± 1.217),(1.464 ± 0.677),(3.325 ± 2.425)μg/L. Compared with rutin group,AUC0-24 h and cmax in quercetin group,BL1 group and BL3 group were significantly increased(P<0.05),tmax and MRT0-24 h were significantly decreased(P<0.05);cmax in BL2 group was significantly increased(P<0.05),tmax and MRT0-24 h were significantly decreased(P<0.05). Compared with quercetin group,except AUC0-24 h was significantly decreased in BL2 group(P<0.05),there were no significant differences in AUC0-24 h,MRT0-24 h,tmax or cmax in BL1 group,BL2 group and BL3 group(P>0.05). CONCLUSIONS:Quercetin can inhance the related indexes of rutin in rats in vivo.
6. Analysis of influencing factors of heart rate deceleration capacity in patients with dilated cardiomyopathy
Fengyan WANG ; Cao ZOU ; Hongkai DONG ; Yichen YANG ; Meiwen GAO ; Ru ZHAO ; Jianling JIN ; Xiangjun YANG
Chinese Journal of Cardiology 2017;45(9):753-757
Objective:
To investigate the determinants affecting the heart rate deceleration capacity (DC) in patients with dilated cardiomyopathy (DCM).
Methods:
One hundred patients with DCM (DCM group) and 202 healthy subjects (control group) were respectively enrolled. Echocardiography and 24 hours electrocardiogram were performed in all subjects. DC value was compared between the two groups. Multiple regression analysis was made to evaluate the related determinants of DC ((age, sex, echocardiographic parameters including the left atrial diameter (LAD) and left ventricular ejection fraction (LVEF)).
Results:
(1) DC value was significantly lower in DCM group than in control group( (4.40±2.03) ms vs. (7.30±1.81) ms,
7.Imaging findings of global choroidal hemangioma
Rongxian ZHOU ; Mingshun ZOU ; Yi LI ; Yichen LI ;
Chinese Journal of Radiology 2001;0(02):-
Objective To describe CT and MRI findings of the global choroidal hemangioma, and to investigate their value in the diagnosis and differentiation. Methods Nine choroidal hemangioma patients proven by surgical pathology( n =3)or clinic information ( n =6) were analyzed. CT scan was performed in 6 cases and MRI in 4 cases. All cases were examined by ultrasound and 3 with fundus fluorescein angiography (FFA). Results Two cases showed slight or crescent like thickening and iso density with respect to the global wall on CT scan. 5 cases on enhanced CT showed a flat or shuttle shaped homogeneous mass with marked enhancement. MRI ( n =3) revealed high signal intensity on T 1WI and low signal intensity on T 2WI with respect to the vitreous. 1 small tumor was found clearly by postcontrast fat suppressed T 1WI. Ultrasound showed homogeneous mass ( n =1) and inhomogeneous mass ( n =8), with retinal detachment in all cases. Conclusion CT + MRI + ultrasound can get most of the diagnostic imaging data for choroidal hemangioma. MRI was superior to CT and ultrasound in the diagnosis of choroidal hemangioma and differential diagnosis from other malignant tumors.


Result Analysis
Print
Save
E-mail